Pfizer Deal Allows Dr. Reddy’s to Sell Depression Pill in U.S.
This article is for subscribers only.
Dr. Reddy’s Laboratories Ltd., India’s second-largest drugmaker, will be allowed to sell a generic version of Wyeth’s antidepressant drug starting June 1 following an agreement with the unit of Pfizer Inc.
Pfizer spokesman Christopher Loder, who confirmed the agreement in an e-mail yesterday, declined to disclose financial terms of the deal. Wyeth, a unit of the world’s largest drugmaker, and Dr. Reddy’s reached a settlement to sell the drug Effexor XR in the New Jersey Federal Court, Press Trust of India reported on April 22.